Ironwood Pharmaceuticals | IRWD - Interest Income


Ironwood Pharmaceuticals reported $778K in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.33M 86K Dec/2025
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Almirall EUR 2.71M 580K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 73M 62M Mar/2026
Charles River Laboratories USD -0.3 1.02M Mar/2026
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Incyte USD 33.69M 2.93M Mar/2026
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 70M 3M Dec/2025
Myriad Genetics USD 300K 0 Mar/2025
Pacira USD 2.3M 6.24M Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025